Outcome of Conservative Therapy in Coronavirus disease-2019 Patients Presenting With Gastrointestinal Bleeding
Autor: | Anugrah Dhooria, Manas Vaishnav, Chandan Palle, Vikas Banyal, Avinash Choudekar, Mukesh Ranjan, Ashutosh Singh, Soumya Jagannath Mahapatra, Anshuman Elhence, Ramesh Kumar, Sulagna Bhattacharjee, Richa Aggarwal, Anjan Trikha, Samagra Agarwal, Anoop Saraya, Deepak Gunjan, Jatin Yegurla, Govind K. Makharia, Kapil Dev Soni, Irfan Altaf, Rajat Bansal, Srikant Mohta, Shalimar, Tanmay Vajpai, Pramod Kumar Garg, Shubham Prasad, Saurabh Kedia, Peeyush Kumar, Swetha Rudravaram |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Proton pump inhibitors
GI Gastrointestinal HVPG Hepatic venous pressure gradient 0302 clinical medicine GBS Glasgow-Blatchford bleeding score Liver transplant Variceal bleeding Gastric antral vascular ectasia Prognosis FFP Fresh frozen plasma 030220 oncology & carcinogenesis CLD Chronic liver disease AIMS65 Albumin Original Article 030211 gastroenterology & hepatology INR International normalized ratio Fresh frozen plasma medicine.drug HE Hepatic encephalopathy medicine.medical_specialty Gastrointestinal bleeding NSAIDs Non-steroidal anti-inflammatory drugs international normalized ratio mental status MOHFW Ministry of Health and Family Welfare 03 medical and health sciences Pharmacotherapy Hemorrhoids COVID-19 Coronavirus disease −2019 medicine PPE Personal protective equipment Hepatology CRS Clinical Rockall Score GAVE Gastric antral vascular ectasia business.industry LGI Lower gastrointestinal Endoscopy SARS-CoV2 Severe acute respiratory syndrome Coronavirus 2 RR Respiratory rate RT-PCR Reverse transcriptase polymerase chain reaction Bleed medicine.disease mGBS Modified Glasgow-Blatchford bleeding score systolic blood pressure age> 65 Surgery UGI Upper gastrointestinal AD Acute decompensation Carvedilol AIH Autoimmune hepatitis PRBC Packed red blood cells Terlipressin business Packed red blood cells |
Zdroj: | Journal of Clinical and Experimental Hepatology |
ISSN: | 0973-6883 |
DOI: | 10.1016/j.jceh.2020.09.007 |
Popis: | Background/Objective There is a paucity of data on the management of gastrointestinal (GI) bleeding in patients with Coronavirus disease -2019 (COVID-19) amid concerns about the risk of transmission during endoscopic procedures. We aimed to study the outcomes of conservative treatment for GI bleeding in patients with COVID-19. Methods In this retrospective analysis, 24 of 1342 (1.8%) patients with COVID-19, presenting with GI bleeding from 22nd April to 22nd July 2020, were included. Results The mean age of patients was 45.8 ± 12.7 years; 17 (70.8%) were males; upper GI (UGI) bleeding: lower GI (LGI) 23:1. Twenty-two (91.6%) patients had evidence of cirrhosis- 21 presented with UGI bleeding while one had bleeding from hemorrhoids. Two patients without cirrhosis were presumed to have non-variceal bleeding. The medical therapy for UGI bleeding included vasoconstrictors-somatostatin in 17 (73.9%) and terlipressin in 4 (17.4%) patients. All patients with UGI bleeding received proton pump inhibitors and antibiotics. Packed red blood cells (PRBCs), fresh frozen plasma (FFPs) and platelets were transfused in 14 (60.9%), 3 (13.0%) and 3 (13.0%), respectively. The median PRBCs transfused was 1 (0–3) unit(s). The initial control of UGI bleeding was achieved in all 23 patients and none required an emergency endoscopy. At 5-day follow-up, none rebled or died. Two patients later rebled, one had intermittent bleed due to gastric antral vascular ectasia, while another had rebleed 19 days after discharge. Three (12.5%) cirrhosis patients succumbed to acute hypoxemic respiratory failure during hospital stay. Conclusion Conservative management strategies including pharmacotherapy, restrictive transfusion strategy, and close hemodynamic monitoring can successfully manage GI bleeding in COVID-19 patients and reduce need for urgent endoscopy. The decision for proceeding with endoscopy should be taken by a multidisciplinary team after consideration of the patient's condition, response to treatment, resources and the risks involved, on a case to case basis. |
Databáze: | OpenAIRE |
Externí odkaz: |